Morgan Stanley’s CapForce IBD 50 ETF FFTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.6K | Hold |
1,093
| – | – | ﹤0.01% | 6532 |
|
|
2026
Q1 | $36.5K | Buy |
1,093
+64
| +6% | +$2.38K | ﹤0.01% | 6535 |
|
|
2025
Q4 | $35.8K | Buy |
1,029
+133
| +15% | +$4.9K | ﹤0.01% | 6530 |
|
|
2025
Q3 | $33.5K | Buy |
896
+546
| +156% | +$18.9K | ﹤0.01% | 6526 |
|
|
2025
Q2 | $11.4K | Sell |
350
-1,000
| -74% | -$28.6K | ﹤0.01% | 6821 |
|
|
2025
Q1 | $36.4K | Buy |
1,350
+999
| +285% | +$29.3K | ﹤0.01% | 6373 |
|
|
2024
Q4 | $10.1K | Sell |
351
-917
| -72% | -$26.7K | ﹤0.01% | 6796 |
|
|
2024
Q3 | $34.1K | Buy |
1,268
+132
| +12% | +$3.48K | ﹤0.01% | 6329 |
|
|
2024
Q2 | $31.6K | Hold |
1,136
| – | – | ﹤0.01% | 6322 |
|
|
2024
Q1 | $31.4K | Buy |
1,136
+15
| +1% | +$392 | ﹤0.01% | 6364 |
|
|
2023
Q4 | $27.3K | Sell |
1,121
-5,345
| -83% | -$122K | ﹤0.01% | 6355 |
|
|
2023
Q3 | $145K | Sell |
6,466
-2,000
| -24% | -$48.3K | ﹤0.01% | 5719 |
|
|
2023
Q2 | $217K | Buy |
8,466
+2,550
| +43% | +$60.4K | ﹤0.01% | 5618 |
|
|
2023
Q1 | $140K | Sell |
5,916
-400
| -6% | -$9.19K | ﹤0.01% | 5870 |
|
|
2022
Q4 | $138K | Sell |
6,316
-500
| -7% | -$12.3K | ﹤0.01% | 5828 |
|
|
2022
Q3 | $166K | Buy |
6,816
+804
| +13% | +$22.3K | ﹤0.01% | 5815 |
|
|
2022
Q2 | $161K | Sell |
6,012
-700
| -10% | -$22.5K | ﹤0.01% | 5995 |
|
|
2022
Q1 | $263K | Buy |
6,712
+3,205
| +91% | +$124K | ﹤0.01% | 5775 |
|
|
2021
Q4 | $161K | Sell |
3,507
-1,185
| -25% | -$56.6K | ﹤0.01% | 6174 |
|
|
2021
Q3 | $223K | Hold |
4,692
| – | – | ﹤0.01% | 5941 |
|
|
2021
Q2 | $218K | Sell |
4,692
-1,095
| -19% | -$49.6K | ﹤0.01% | 5967 |
|
|
2021
Q1 | $254K | Sell |
5,787
-500
| -8% | -$22.7K | ﹤0.01% | 5517 |
|
|
2020
Q4 | $258K | Sell |
6,287
-148
| -2% | -$5.77K | ﹤0.01% | 5459 |
|
|
2020
Q3 | $240K | Sell |
6,435
-1,648
| -20% | -$60.7K | ﹤0.01% | 5017 |
|
|
2020
Q2 | $279K | Buy |
8,083
+794
| +11% | +$24.7K | ﹤0.01% | 4911 |
|
|
2020
Q1 | $204K | Sell |
7,289
-1,820
| -20% | -$60.6K | ﹤0.01% | 4856 |
|
|
2019
Q4 | $316K | Sell |
9,109
-1,866
| -17% | -$63.1K | ﹤0.01% | 5178 |
|
|
2019
Q3 | $354K | Buy |
10,975
+473
| +5% | +$16.2K | ﹤0.01% | 4843 |
|
|
2019
Q2 | $360K | Buy |
10,502
+8,940
| +572% | +$301K | ﹤0.01% | 4765 |
|
|
2019
Q1 | $52K | Sell |
1,562
-1,771
| -53% | -$55.7K | ﹤0.01% | 5648 |
|
|
2018
Q4 | $92K | Sell |
3,333
-4,068
| -55% | -$126K | ﹤0.01% | 5584 |
|
|
2018
Q3 | $285K | Buy |
7,401
+3,584
| +94% | +$132K | ﹤0.01% | 5288 |
|
|
2018
Q2 | $134K | Buy |
3,817
+1,350
| +55% | +$47.1K | ﹤0.01% | 5668 |
|
|
2018
Q1 | $83K | Buy |
2,467
+663
| +37% | +$22.6K | ﹤0.01% | 5756 |
|
|
2017
Q4 | $60K | Buy |
1,804
+760
| +73% | +$25.2K | ﹤0.01% | 5777 |
|
|
2017
Q3 | $33K | Sell |
1,044
-287
| -22% | -$8.49K | ﹤0.01% | 5898 |
|
|
2017
Q2 | $36K | Buy |
1,331
+345
| +35% | +$9.26K | ﹤0.01% | 5940 |
|
|
2017
Q1 | $25K | Buy |
+986
| New | +$24.6K | ﹤0.01% | 6021 |
|
|
2016
Q1 | – | Sell |
-900
| Closed | -$20K | – | 6617 |
|
|
2015
Q4 | $20K | Sell |
900
-4,411
| -83% | -$101K | ﹤0.01% | 6033 |
|
|
2015
Q3 | $116K | Buy |
5,311
+661
| +14% | +$15.8K | ﹤0.01% | 5353 |
|
|
2015
Q2 | $117K | Buy |
+4,650
| New | +$116K | ﹤0.01% | 5501 |
|
Other funds holding FFTY
IWM
DSCM
CPIG
CFP
Morgan Stanley's FFTY Position: Q2 2026 in Review
Morgan Stanley held its CapForce IBD 50 ETF (FFTY) position steady in Q2 2026 at 1,093 shares worth $47.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6532.
Morgan Stanley first reported a position in FFTY in Q2 2015 and has held it in 41 quarters since. The position peaked at $360K in Q2 2019. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.
- Morgan Stanley held 1,093 shares of CapForce IBD 50 ETF worth $47.6K as of Q2 2026.
- Morgan Stanley left its CapForce IBD 50 ETF share count unchanged in Q2 2026.
- CapForce IBD 50 ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6532 holding.
- Morgan Stanley first reported a position in CapForce IBD 50 ETF in Q2 2015 and has held it in 41 quarters since.
- Morgan Stanley's CapForce IBD 50 ETF position peaked at $360K in Q2 2019.
- 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.